Get started
Author

Gabriel L. Butterfield

Observed name: Gabriel Butterfield
Institution: Duke University
ORCID: 0000-0002-6825-6286
Observed ORCID: 0000-0002-6825-6286
OpenAlex ID: A5068780843
Evolution of a designed protein assembly encapsulating its own RNA genome
2017 · Gabriel L. Butterfield, Marc J. Lajoie, et al. · Nature · 199
Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
2014 · Steven M. Offer, Croix C. Fossum, et al. · Cancer Research · 185
microRNAs miR-27a and miR-27b Directly Regulate Liver Dihydropyrimidine Dehydrogenase Expression through Two Conserved Binding Sites
2014 · Steven M. Offer, Gabriel L. Butterfield, et al. · Molecular Cancer Therapeutics · 89
Gene regulation technologies for gene and cell therapy
2025 · Gabriel L. Butterfield, Samuel J. Reisman, et al. · Molecular Therapy · 35
Characterization of diverse Cas9 orthologs for genome and epigenome editing
2025 · Gabriel L. Butterfield, Dahlia Rohm, et al. · Proceedings of the National Academy of Sciences · 12
PDF
In vivo selection of synthetic nucleocapsids for tissue targeting
2023 · Audrey Olshefsky, Halli Benasutti, et al. · Proceedings of the National Academy of Sciences · 8
Resurrecting a miniature Cas9 ancestor for genome and epigenome editing
2025 · Gabriel L. Butterfield, Charles A. Gersbach · Nature Biotechnology · 1
Abstract 2198: Possible circadian modulation of dihydropyrimidine dehydrogenase by mir-27a and mir-27b.
2013 · Gabriel L. Butterfield, Steven M. Offer, et al. · Cancer Research · 1
Data from Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
2023 · Steven M. Offer, Croix C. Fossum, et al.
Supplementary Figure 1 from Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
2023 · Steven M. Offer, Croix C. Fossum, et al.
Supplementary Tables 1 - 3 from Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
2023 · Steven M. Offer, Croix C. Fossum, et al.
PDF
Supplementary Figure 1 from Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
2023 · Steven M. Offer, Croix C. Fossum, et al.
PDF
Supplementary Tables 1 - 3 from Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
2023 · Steven M. Offer, Croix C. Fossum, et al.
Data from Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase Activity
2023 · Steven M. Offer, Croix C. Fossum, et al.
Evolution of Synthetic Nucleocapsids Encapsulating their own RNA genome
2018 · Gabriel L. Butterfield · ResearchWorks at the University of Washington (University of Washington)
PDF
Abstract B073: Protein nanoparticles for controllable T cell activation
2016 · Marc J. Lajoie, Gabriel Butterfield, et al. · Cancer Immunology Research
Works count: 16
Citation count: 530
H-index: 6
I10-index: 5
Year
Topic
Type